Navigation Links
WellPoint Reports First Quarter 2008 Results
Date:4/23/2008

-- Medical enrollment grew by 564,000 members during the first quarter of

2008 -- Net income was $1.07 per share, including net realized investment losses

of $0.06 per share -- Operating cash flow was $1.0 billion, or approximately 1.8 times net

income -- Full year 2008 net income is now expected to be in the range of $5.42 - $5.67 per share, including net realized investment losses of $0.06 per

share

INDIANAPOLIS, April 23 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP) today announced that first quarter 2008 net income was $588.1 million, or $1.07 per share, which included net realized investment losses of $0.06 per share. Net income in the first quarter of 2007 was $783.1 million, or $1.26 per share.

"While the first quarter was challenging for WellPoint, since our March announcement we have further reduced claims inventories and achieved greater visibility into medical costs," said Angela F. Braly, president and chief executive officer of WellPoint, Inc. "Consequently, we have refined our earnings forecast to reflect higher medical costs and a lower level of favorable prior year reserve development."

"Our overall enrollment growth remains strong and we are now serving 35.4 million medical members, more than ever before. We offer access to the largest provider network in the industry, with competitive pricing, distinctive care management and wellness programs, and innovative medical cost transparency tools. We will continue to enhance this superior value proposition with new product offerings in order to drive future membership gains and long-term earnings growth," added Braly.

"Operating cash flow was strong in the first quarter, at $1.0 billion, or 1.8 times net income, and our medical claims payable increased by $610 million, or 10.5 percent, while claims inventories declined.
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Shareholder Class Action Filed Against WellPoint, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
2. WellPoint Appoints Kevin R. Hayden as President of State Sponsored Business
3. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of WellPoint, Inc. Who Invested in the WellPoint Retirement Savings Plan
4. WellPoint to Hold Conference Call and Webcast to Discuss First Quarter Results On April 23, 2008
5. WellPoints Health Plans to Cover Newly Approved Cancer Treatment
6. WellPoint Announces Appearances at Upcoming Conferences
7. WellPoint Revises 2008 Earnings Per Share Guidance
8. WellPoint Announces Appearance at Upcoming Conference
9. WellPoint Reports Fourth Quarter and Full Year 2007 Results
10. WellPoint Announces Consumer Innovation Opportunity
11. WellPoint Appoints Brian A. Sassi as President and CEO of the Companys Consumer Business Unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...gic reactions in children has revealed that, only ...ects are in need of medical treatment at hospitals...rgic symptoms. The study, entitled “Allergic react...survey of 10,000 junior high school children in Is...
...sity of North Carolina, Chapel Hill it is very muc...cell gene for the normal development of the eye. /...ifferentiate into any type of cell of the nervous ... results in the formation of neurons and optic ner...
...in reliever and fever reducer after a heart attack...e results of a new study using sheep and rabbits c...could have implications for people who have suffer...e in the U.S. each year, said researcher Robert C....
...d a study that has delved into the mental psyche o...deep scars that take very long to heal. // A team... by sociology graduate student David Russell, anal...ts who had survived the1992’ Hurricane Andrew. The...
Other Medicine News:Health News:Insect Bites Among Children Do Not Warrant Medical Attention In Most Cases 2Health News:Importance of Gene in Eye Development 2Health News:Acetaminophen does not Protect Heart Muscle 2Health News:Acetaminophen does not Protect Heart Muscle 3
(Date:9/5/2008)...swire-USNewswire/ -- A team of,researchers at West...s from,India and Pakistan take on the habits of th...state cancer among male immigrants and breast canc...ncer develop due to many reasons, but,environmenta... cancers,",said Jame Abraham, M.D., medical direct...
(Date:9/4/2008)...Newswire/ -- Cytopia Limited (ASX:,CYT) today anno...e Ib/II,study of CYT997, the company,s novel vascu...an aggressive form of brain cancer known as gliobl...is the first Phase II efficacy study in highly,vas... the second in its,suite of Phase II studies desig...
(Date:9/4/2008)...swire-FirstCall/ -- BioForm Medical,Inc. (Nasdaq:... study of,Polidocanol, conducted in Germany by Bio... & Co. GmbH (Kreussler), successfully met the stud...s part of a New Drug Application,(NDA) process., ...icacy and safety of,Aethoxysklerol compared to Sod...
(Date:9/4/2008)..., and Presented at ESC Congress-, PHILADELPHIA, S...ional,study, the GISSI Heart Failure (GISSI-HF) st...esters reduced all cause mortality and hospital,ad...th chronic heart,failure. These findings are publi... and were presented at the European Cardiovascular...
Breaking Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month 261 1Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month 261 2Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month 261 3Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month 261 4New nurses report job stress need for better management 1151 1New nurses report job stress need for better management 1151 2AtriCure to Present at ThinkEquity Partners 5th Annual Growth Conference 1150 1AtriCure to Present at ThinkEquity Partners 5th Annual Growth Conference 1150 2Healthcare Workers Rally to Address Concerns About Layoffs and Quality Patient Care 1147 1Healthcare Workers Rally to Address Concerns About Layoffs and Quality Patient Care 1147 2
... Londe, M.D. Contributing Editor The outcome of ma...ensive care units (ICUs) has not improved dramatic...t of high-tech monitors and sophisticated mechanic...ems. Indeed, critically ill patients requiring in...cent risk of death and substantial morbidity. Rec...
... Londe, M.D. Contributing Editor Clinical guidelin...ry and emergency medicine have all emphasized the ...ing out acute myocardial infarction. The measurem...he large fraction of patients presenting with acut...d EKGs. About 30% of patients previously consider...
Other Medicine Technology:Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 2Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 3
WorldHeart's Novacor LVAS is an implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure. ,Novacor LVAS has been implanted in more
...s first minimally-invasive epicardial lead placeme... Implant Tool, which has been cleared for marketin...ailable to implanting physicians who place the Med...er implants. The tool furthers the trend moving aw...
It is a cardio-pulmonary exercise testing device.
...patient safety, dependability and overall performa...vides an extra margin of safety for patients. The...tandstill to accommodate severely debilitated pati...ilitates accurate blood pressure measurements even...
Medicine Products: